Fig. 5From: The effects of BAFF on T lymphocytes in chronic obstructive pulmonary diseaseEffects of B cell activating factor (BAFF) on cytokine expression of CD4+ cells from COPD patients. CD4+ cells isolated from COPD patients were treated with control, recombinant human BAFF (rhBAFF) or rhBAFF plus BR3-Fc (BAFF antagonist) and the expression levels of interferon-γ (IFN-γ) and interleukin-4 (IL-4) were detected. The relative mRNA levels of IFN-γ (a) and IL-4 (b) in the CD4+ cells from COPD patients (n = 12) are shown. The relative protein levels of IFN-γ (c) and IL-4 (d) in the supernatant of CD4+ cells from COPD patients (n = 12) are shown. *P < 0.05. NS, nonsignificantBack to article page